Genetic Factors Affecting Antibody Response to Pertussis Vaccination
Author Information
Author(s): Kimman Tjeerd G., Banus Sander, Reijmerink Naomi, Reimerink Johan, Stelma Foekje F., Koppelman Gerard H., Thijs Carel, Postma Dirkje S., Kerkhof Marjan
Primary Institution: Center for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
Hypothesis
Are single nucleotide polymorphisms (SNPs) in the Toll-like receptor (TLR) signaling pathway associated with the antibody response to pertussis vaccination in children?
Conclusion
The study identified significant interactions between genes in the TLR pathway that are important for vaccine-induced immunity.
Supporting Evidence
- Significant associations were found between PT-IgG titers and SNPs in several genes including CD14, TLR4, and TOLLIP.
- Two SNPs in TOLLIP showed strong evidence for association with vaccine response.
- Multifactor Dimensionality Reduction Analysis revealed significant interactions between multiple SNPs.
Takeaway
This study looked at how certain genes affect how well kids respond to the whooping cough vaccine, finding that some gene combinations can help make the vaccine work better.
Methodology
The study analyzed associations of 75 haplotype-tagging SNPs in genes of the TLR4 signaling pathway with pertussis toxin (PT)-IgG titers in a cohort of vaccinated children.
Potential Biases
Potential biases may arise from the selection of SNPs and the population studied, which may not represent broader demographics.
Limitations
The findings may not be generalizable due to the specific population studied and the associations did not withstand correction for multiple testing.
Participant Demographics
Children aged one year from the KOALA Birth Cohort Study in the Netherlands.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website